Now let me perform the calibration search to score the paper.**Round 1 bracket: 5.0–7.0** based on comparisons. Let me narrow with Round 2.Now I have enough to write the comprehensive final review. Let me synthesize everything.

---

## Summary

ProteinVista is a 3D CNN that voxelizes every heavy atom of a protein at 1Å resolution into 5-channel density grids, processes them through five convolutional blocks with global average pooling to produce a 1024-dimensional embedding, and is pre-trained on ~500k AlphaFold-2 structures using either contrastive alignment to ESM-2 sequence embeddings or multi-task regression on Rosetta physicochemical scores. The paper evaluates ProteinVista on enzyme-substrate classification (ESP), transporter-substrate classification (TSP), IC₅₀ affinity regression (BindingDB), and GO annotation, demonstrating competitive or superior performance versus ESM-2 on the three structure-sensitive tasks at a fraction of the pre-training compute cost.

---

## Strengths

- **Substantive IC₅₀ regression improvement**: ProteinVista achieves R² = 0.69 vs. R² = 0.61 for ESM-2₆₅₀M on the BindingDB benchmark (Table 2), a 13% relative improvement, confirmed with a Wilcoxon signed-rank test at p < 10⁻³⁰⁴. This is the paper's most compelling empirical result and directly supports the claim that full-atom geometric encoding is informative for affinity prediction beyond what sequence captures.

- **Convincing ensemble complementarity evidence**: The ESM-ProteinVista ensemble improves over ESM-2₆₅₀M alone on both classification benchmarks with McNemar p < 10⁻¹³ (TSP) and p < 10⁻¹⁷ (ESP) (Table 1, Section 3.2), and this complementarity is consistent across all sequence-identity and structural-similarity bins (Figure 2a, 2b), ruling out the explanation that gains are concentrated in a narrow regime.

- **Well-controlled ablation quantifying design choices**: Section 4.2 cleanly isolates the contribution of multi-view inference (6.4% R² drop when reduced to a single view), voxel resolution (1.1% drop at 1.5Å), and pre-training objective (1.0% drop for Rosetta vs. contrastive), providing meaningful guidance about what drives performance.

- **Compute and data efficiency, quantified**: ProteinVista uses 123M parameters, ~0.5M structures, and 48 GPU-hours on 4 A100s for pre-training, versus 650M parameters, 250M sequences, and ~21,000 GPU-hours for ESM-2₆₅₀M (Section 4.3). Training throughput of 1,000 proteins in 20s vs. 426s for ESM-2₆₅₀M is measured and reported directly.

- **Informative stratification analysis**: Figure 2a–c partitions test performance by sequence identity, TM-score, and AlphaFold pLDDT, showing ProteinVista is strongest when structural training coverage is high and structure quality is high (pLDDT > 90), and Figure 2d confirms most test proteins fall in that high-confidence regime—substantiating that the gains are not restricted to a narrow subset.

---

## Weaknesses

### Fatal
None.

### Major

- **Pre-training confound undermines the central "structure vs. sequence" comparison**: ProteinVista's primary variant is pre-trained by contrastively aligning its structural embeddings to ESM-2 sequence embeddings (Section 2.3, Figure 1d). The paper then presents the central comparison as "ProteinVista vs. ESM-2," framing it as evidence that 3D geometry captures information beyond what sequences encode. However, ProteinVista's representations were explicitly shaped by ESM-2's embedding space during pre-training; it is not a structure-only model. The ablation in Section 4.2 reports that the Rosetta-pre-trained variant (no ESM-2 signal) loses only 1.0% R² on IC₅₀—suggesting the pure structural signal is real and close—but this variant is never evaluated on the classification benchmarks (TSP, ESP) or against SOTA baselines. The claim that "full-atom 3D CNNs are superior to protein transformers for structure-dependent tasks" therefore rests on a model that has distilled sequence representations into its weights. The core argument survives qualitatively given the ablation, but the comparison is not as clean as presented; showing the Rosetta-pre-trained variant on all three tasks would decisively close this gap.

- **SOTA comparison margins are thin and lack statistical qualification**: In Section 3.3, ESM-ProteinVista_OP outperforms SPOT on TSP by 0.8 pp (93.2% vs. 92.4%) and ProSmith-ESP/Fusion_ESP on ESP by 0.2 pp (94.4% vs. 94.2%). In contrast to the ESM-vs-ProteinVista comparison (McNemar's test, McNemar p < 10⁻¹³), no statistical test is reported for the SOTA comparisons, leaving the headline claim of beating state-of-the-art statistically unsubstantiated. The optimized pipeline (OP) also adds a contrastive fine-tuning network not applied to the SOTA baselines, so it is not established that the pipeline upgrade alone doesn't close the gap.

### Minor

- **Abstract overstates ensemble benefit**: The abstract states "A simple ensemble with ESM-2 can further improve accuracy," but Table 2 shows the ensemble actually *hurts* on IC₅₀ (R² = 0.68 vs. 0.69 for ProteinVista alone). The statement holds for the classification tasks but not universally, and the abstract should be corrected.

- **Inference-time compute claim is inconsistent**: Section 4.3 and Figure 3c present the 20s/1,000 proteins figure as measured "during training," but the caption labels it "Inference Time on Single A100." Since Section 4.2 confirms 5 augmented views are averaged at inference time, actual inference cost is approximately 5× the training-pass cost (~100s for 1,000 proteins), reducing the efficiency advantage over ESM-2₁₅₀M (215s) from ~10× to ~2×. The efficiency claims are still meaningful but should be reported at the actual inference cost.

- **BindingDB train/test split not described**: The paper does not specify whether the BindingDB IC₅₀ benchmark uses a random split, a protein-stratified split, or another splitting strategy. For a dataset where proteins appear repeatedly with different ligands, split methodology materially affects whether the IC₅₀ result measures generalization to new targets or affinity-range memorization. Clarifying the split protocol is important for reproducibility.

### Trivial

- **"Rotational invariance" overstated**: Figure 1 caption says "To enforce rotational invariance" but the augmentation covers only the 48-element discrete group (90° rotations + mirror reflections), not continuous SO(3). Section 2.4 correctly uses "rotation-robust"—the caption should be aligned to use the same terminology.

---

## Nice-to-Haves

- Extending ablation results (Rosetta-pre-trained variant) to TSP and ESP would transform the central claim from "a model partially distilled from ESM-2 outperforms ESM-2" to "a purely structure-trained model outperforms sequence-only," making the paper's argument much stronger.
- Reporting IC₅₀ results broken down by protein family or binding-pocket diversity would test whether the affinity advantage is broad-based or concentrated in AlphaFold-well-covered targets.
- A parity check between training-time and inference-time throughput, reflecting the 5-view cost, would make the efficiency claims fully consistent.
- An interpretability example using Grad-CAM (mentioned in Section 5) would be a compelling figure demonstrating ProteinVista autonomously highlights known binding-site residues.

---

## Removed Points

*These points are flagged to be removed — treat them with caution.*

- **Density formula "parsing artifact" (Harsh Critic, Section 2.3)**: The critic flags the voxel density formula notation as garbled. Per hard rules, OCR/parser artifacts are not author errors and must not be included as weaknesses.

- **"Template-based feature matching" at high sequence identity (Harsh Critic, Section 4.1)**: The critic suggests that ProteinVista's advantage at high identity might reflect template matching rather than learned geometry. This is speculative and not grounded in anything on the page; it is an alternative interpretation hypothesis rather than an identified flaw.

- **"Rotational invariance covers only a discrete subset of SO(3)" as a Major weakness**: This is real but minor, flagged only as trivial presentation precision. The practical impact on results is nil—the ablation shows the approach works well.

- **Strength Finder strength about "more than two orders of magnitude less data"**: While numerically correct (~0.5M vs. 250M), the comparison is sequences vs. structures (different data types), and the efficiency is for pre-training only. Kept as concrete efficiency evidence but narrowed in scope.

---

## Novel Insights

The most genuinely novel insight across both reviewers is the interaction between discrete-group rotation augmentation during *pre-training* and multi-view inference: disabling augmentation during fine-tuning barely affects performance (−0.1%), yet removing multi-view aggregation at inference drops R² by 6.4%. This implies the rotation robustness mechanism is absorbed into the pre-trained weights, not the task-specific fine-tuning stage—a finding with direct implications for how future 3D CNN protein models should be designed and deployed. The stratification finding (ProteinVista excels at high sequence identity, while ESM-2 is relatively better at low identity) also suggests a concrete complementarity mechanism: structural models interpolate within known folds, while sequence models generalize across evolutionary distance.

---

## Suggestions

1. Report the Rosetta-pre-trained variant on TSP and ESP (Table 1) as a supplementary row. Even a 1–2 pp drop would isolate the pure structural contribution and address the ESM-2 distillation concern directly.
2. Correct the abstract to qualify that the ensemble benefit is task-dependent (helps on classification, hurts on IC₅₀).
3. Report inference time with 5 views explicitly in Figure 3c or in Section 4.3, and correct the figure caption label.
4. Add a sentence clarifying the BindingDB train/test split strategy.
5. Align Figure 1 caption language on "rotational invariance" with Section 2.4's "rotation-robust."

---

## Score and Decision

**Calibration anchors (all rounds):**

| Path | Avg Score | Round | Comparison to ProteinVista |
|---|---|---|---|
| jqx5XI4Yr3 (ProteinAdapter) | 3.40 | 1 | Weaker — adapter work with no strong benchmark results |
| rEQ8OiBxbZ (LEGO 3D mol pretraining) | 3.00 | 1 | Weaker — less coherent methodology and results |
| AXbN2qMNiW (Protein-ligand binding SSL) | 5.67 | 1 | Comparable — protein-ligand task, similar scope, no compute efficiency story, similar quality of experiments |
| ARQIJXFcTH (AtomSurf) | 6.75 | 1 | Slightly stronger — achieves SOTA on all Atom3D tasks, no pre-training confound |
| BEH4mGo7zP (ProteinINR) | 5.75 | 1 | Comparable — multi-modal pre-training with surface features, similar experimental rigor |
| xNDydjYBmC (PPBind) | 4.60 | 1 | Weaker — less novel, narrower scope |
| sTYuRVrdK3 (ProteinWorkshop) | 6.25 | 2 | Similar — benchmark suite for protein structure GNNs; broader scope but no strong method-level result |
| OzUNDnpQyd (Structure Language Models) | 7.00 | 2 | Stronger — fundamental generative architecture, strong benchmark coverage |
| 6MRm3G4NiU (SaProt) | 7.33 | 2 | Stronger — large-scale PLM with structure-aware vocabulary, pre-trained at massive scale |

**Round 1 bracket**: 5.0–7.0

**Round 2 narrowing**: The most topically similar anchors in the bracket are ProteinWorkshop (6.25) and AtomSurf (6.75). ProteinVista is:
- *Stronger* than ProteinWorkshop: it is a new method with a real performance advantage over strong baselines, not just a benchmark; the IC₅₀ result is compelling.
- *Weaker* than AtomSurf: AtomSurf achieves SOTA across all Atom3D tasks without a pre-training confound; its SOTA claims are methodologically cleaner.
- *Weaker* than OzUNDnpQyd/SaProt: those papers represent more fundamental architectural innovations at larger scale.

The pre-training confound (ESM-2 distillation weakening the central comparative claim), thin unstatisticized SOTA margins, and the inference-cost reporting inconsistency together pull the paper below AtomSurf. The strong IC₅₀ result, complementarity evidence, and informative ablation put it above the 5.67–5.75 cluster. The abstract inaccuracy and missing split description are additional minor debits.

**Final bracket**: 5.5–6.0, with the balance of evidence pointing toward the lower end given that the central "structure outperforms sequence" argument depends on a pre-training confound not fully resolved by the ablation.

**Originality**: Moderate — applying 3D CNNs to full-atom proteins is not entirely new (e.g., DeepSite, EnzyNet) but doing so at this scale with strong downstream results is novel. The contrastive pre-training against ESM-2 is straightforward.
**Importance of research question**: High — structure vs. sequence for protein-ligand prediction is a core open question.
**Claim support**: Moderate — strong on IC₅₀, adequate on classification, weakened on SOTA comparison (thin margins, no stats) and the pre-training confound undermines the cleanest structural argument.
**Soundness**: Good overall; main concern is methodological framing, not implementation.
**Clarity**: Good, with one abstract inaccuracy and one figure caption inconsistency.
**Value to community**: Real — especially for practitioners using 3D CNNs for binding prediction.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>